Raffaella Quintana > DLA Piper > Rome, Italy > Lawyer Profile

DLA Piper‘s broad practice covers corporate compliance programmes, internal investigations, international sanctions, crime prevention, anti-money laundering, and anti-bribery and corruption. Other key areas are regulatory investigations, export controls, antitrust compliance, data protection compliance, and tax and budget fraud. The team is co-led by pharmaceutical and medical device industry specialist Raffaella Quintana, who is ‘one of the greatest compliance experts around’; and Antonio Carino, who defends major corporations against Decree 231-related criminal proceedings. The department also includes Francesco Lalli and Raffaele Perfetto, who both advise on corporate criminal liability matters.

DLA Piper’s broad offering regularly handles cross-border joint ventures, private equity investment mandates, and clinical trial agreements for its lucrative, global client base of pharma and biotech companies. Practice head Roberto Valenti is well-equipped to assist clients with the full range of soft IP disputes and commercial issues surrounding medical devices. Marco de Morpurgo divides his time between Rome and Brussels, with his primary area of expertise being EU and Italian regulation of biotech, medical devices, and pharma products. Raffaella Quintana stands out due to her longstanding expertise in internal investigations and commercial fraud matters within the life sciences space, often representing pharma companies, while regulatory expert Nicola Landolfi is known for his vast knowledge of both EU and Italian law governing the licensing of products and clinical trials.